 |
Asset
is a fully integrated, uHTS high content
screening system that can process a plate
every 30 seconds, with one operator using
any assay technology. |
| |
Asset offers a unique combination
of flexibility, assay quality (Z') and throughput. |
| |
Asset is operational at major
pharmaceutical sites, including GlaxoSmithKline
and AstraZeneca,
routinely screening large compound libraries
against a wide range of assay types. |
| |
|
| Asset
automates: |
| |
- High content screening system : batch
sizes in excess of 400 plates with lids
(96, 384 or 1536 well) using PlateSafes
- Reagent addition using temperature
controlled reservoirs with optional
gassing and agitation
- Tip washing and drying, in parallel
with pipetting
- Tissue culture quality incubation
with CO2 and humidity control
- Finely controlled plate washing for
cell-based, coated-well and ELISA procedures
- Signal detection using multiple readers
of user’s choice
- Complete sample tracking giving full
audit trail
- Unlimited multi-stream transfers between
compound, cell and assay plates within
an assay
|
| Asset
offers: |
| |
- Processing capacity to handle all
likely workloads - screens 250,000 compounds
in 8 hours, to meet peak demands and
complete high priority screens quickly,
in keeping with high content screening
systems requirements
- Consistent and reproducible results
for even complex multi-stream uHTS assays
- using Asset’s proprietary plate
indexing system
- Flexibility to assemble and measure
the full range of assays – ELISAs,
as well as sensitive cell-based assays
- Rapid and simple changeover between
different assays
- Reliable, unattended operation enables
extended-hours runs
- Choice of user-specified assay technology
and plate readers
|
| |
Asset’s
unique processing style delivers optimised
Z’ values at uHTS throughputs, regardless
of assay format. This enables screening
groups to deliver enhanced service to their
clients in therapeutic areas. |
| Applications
include: |
| |
- High content screening
- Ultra high throughput screening (uHTS)
|
| |
For
more information on Asset: |
| |
Get more
detail on the high
content screening systems |
| |
Discuss
your requirements with Ian
Ransome, Sales Director |
|
